Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PD180970 |
Trade Name | |
Synonyms | PD 180970 |
Drug Descriptions |
PD180970 is an ATP-competitive tyrosine kinase inhibitor of Src and Abl, which can result in the inhibition of autophosphorylation and induce apoptosis (PMID: 10974196, PMID: 12499247, PMID: 27699828). |
DrugClasses | BCR-ABL Inhibitor 32 SRC Inhibitor 31 |
CAS Registry Number | 287204-45-9 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PD180970 | PD180970 | 0 | 0 |
PD180970 + Serdemetan | PD180970 Serdemetan | 0 | 0 |